Insulet Corporation - Common Stock (PODD)
144.94
+2.29 (1.61%)
NASDAQ· Last Trade: May 30th, 4:07 AM EDT
Detailed Quote
| Previous Close | 142.65 |
|---|---|
| Open | 142.11 |
| Bid | 143.58 |
| Ask | 147.00 |
| Day's Range | 141.65 - 145.13 |
| 52 Week Range | 140.63 - 354.88 |
| Volume | 2,077,968 |
| Market Cap | 9.98B |
| PE Ratio (TTM) | 41.53 |
| EPS (TTM) | 3.5 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 1,921,215 |
Chart
About Insulet Corporation - Common Stock (PODD)
Insulet Corp is a healthcare company specializing in the development and manufacturing of innovative insulin delivery systems for individuals with diabetes. The company is best known for its Omnipod Insulin Management System, a tubeless, waterproof device that allows users to deliver insulin discreetly and conveniently without the need for traditional syringes or infusion sets. Insulet is committed to enhancing the quality of life for diabetes patients by providing advanced technology solutions that simplify insulin management, improve glycemic control, and promote independence in self-care. Through ongoing research and development, Insulet aims to lead the way in diabetes management innovation. Read More
News & Press Releases
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the William Blair 46th Annual Growth Stock Conference in Chicago on Wednesday, June 3, 2026 at 2:00 p.m. (Central Time).
By Insulet Corporation · Via Business Wire · May 27, 2026
Which S&P500 stocks are moving on Wednesday?chartmill.com
Via Chartmill · May 27, 2026
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Via Chartmill · May 27, 2026
What's going on in today's after hours session: S&P500 moverschartmill.com
Via Chartmill · May 26, 2026
Insulet Corp (NASDAQ:PODD) Blows Past Q1 Estimates, Raises Full-Year Revenue Guidancechartmill.com
Via Chartmill · May 6, 2026
INSULET CORP (NASDAQ:PODD): A Textbook GARP Candidate for Affordable Growth Investorschartmill.com
Via Chartmill · May 1, 2026
Gapping S&P500 stocks in Wednesday's sessionchartmill.com
Via Chartmill · May 27, 2026
These S&P500 stocks are moving in today's pre-market sessionchartmill.com
Via Chartmill · May 27, 2026
Insulet Corporation, Inc. (NASDAQ: PODD) (“Insulet” or the “Company”) today announced a voluntary Medical Device Correction for specific lots of Omnipod® 5, Omnipod DASH®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identified through ongoing product monitoring, that could result in insulin under-delivery.
By Insulet Corporation · Via Business Wire · May 26, 2026
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...
Via StockStory · May 24, 2026
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Via Chartmill · May 13, 2026
Insulet’s first quarter was marked by robust revenue growth, driven by continued adoption of its Omnipod 5 insulin delivery system across both U.S. and inter...
Via StockStory · May 13, 2026
What Happened? Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 3.4% in the afternoon session after Benchmark initiated coverage o...
Via StockStory · May 12, 2026
Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more pr...
Via StockStory · May 11, 2026
Which S&P500 stocks are moving on Thursday?chartmill.com
Via Chartmill · May 7, 2026
Wednesday's session: top gainers and losers in the S&P500 indexchartmill.com
Via Chartmill · May 6, 2026
Insulet (PODD) Q1 2026 Earnings Transcript
Via The Motley Fool · May 6, 2026
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Via Chartmill · May 6, 2026
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 33.9% year on...
Via StockStory · May 6, 2026
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the three months ended March 31, 2026.
By Insulet Corporation · Via Business Wire · May 6, 2026
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the publication of its 2025 Sustainability Report, showcasing progress across its operations, products, people, and community. The report underscores how Insulet’s sustainability strategy continues to strengthen its mission of transforming life for people with diabetes while preserving the health of our planet.
By Insulet Corporation · Via Business Wire · May 5, 2026
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what investors should know. Insulet beat...
Via StockStory · May 4, 2026
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has enrolled the first participant in a pivotal study for its fully closed-loop (FCL)A automated insulin delivery (AID) system for type 2 diabetes (T2D). FCL for T2D is a breakthrough innovation intended to further improve glycemic outcomes with less burden for users across diverse care settings. That includes eliminating user interactions for bolusing and mealtime announcements for people with T2D as well as settings to start and onboard.
By Insulet Corporation · Via Business Wire · May 4, 2026